Rare diseases
Investigational molecules
Locations
A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration
BulgariaStudy Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration
CzechiaStudy on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration
CzechiaStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
AustriaStudy of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg
AustriaStudy Comparing Avelumab and Standard Chemotherapy for Patients with Metastatic Colorectal Cancer with Microsatellite Instability
FrancePreventing Neovascular Glaucoma in Patients with Large Choroidal Melanoma Using Aflibercept During Proton Therapy
FranceLong-Term Study on Aflibercept for Retinopathy of Prematurity in Children
BulgariaStudy on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)
FranceStudy on Faricimab and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration Receiving Frequent Aflibercept Treatment
AustriaStudy on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration
FranceStudy Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
